The Daily Papule

Pediatr DermCase report

Pediatric Lichen Planus Pemphigoides in a Child With Sickle Cell Disease

Cyclosporine Induction and Dupilumab Maintenance.

Engelking YT, Ferrer LC, Newton J, Berrebi KG

Pediatric DermatologyIn the feed 8 Oct 2026, published online 8 Oct 2026, issue 2026 Oct 08, added to PubMed 8 Oct 2026

Topics: Lichen planus & lichenoidAutoimmune & connective tissuePediatric dermatologyDermatopathology

Abstract

Lichen planus pemphigoides (LPP) is a rare autoimmune subepidermal blistering disorder that combines lichenoid lesions of lichen planus with immunopathologic features of pemphigoid disease. We report an 8-year-old boy with homozygous sickle cell disease and severe atopic dermatitis who developed diffuse pruritic violaceous papules followed by tense bullae; subsequent histopathologic, immunofluorescence, and serologic findings confirmed LPP. The patient was initially treated with cyclosporine, with marked clinical improvement within 2-3 weeks. Dupilumab was subsequently initiated during the cyclosporine taper, and no recurrent bullae were observed through approximately 8 months of follow-up.

Abstract from PubMed

PMID 42847746 · DOI 10.1111/pde.70360